INSYS Therapeutics’ Board of Directors and management are committed to responsible corporate governance to ensure that INSYS is managed for the long-term benefit of its stockholders. To that end, the Board of Directors and management review published guidelines and recommendations of institutional stockholder organizations and current best practices of similarly situated public companies. The Board and management periodically evaluate and, when appropriate, revise INSYS’ corporate governance policies and practices in light of these guidelines and practices and to comply with the requirements of the Sarbanes-Oxley Act of 2002 and the rules and listing standards issued by the Securities and Exchange Commission (“SEC”) and The Nasdaq Stock Market, Inc. (“Nasdaq”).
Committee Charters
Download Corporate Governance DocumentationAudit Committee
Download Corporate Governance DocumentationCompensation Committee
Download Corporate Governance DocumentationNominating and Corporate Governance Committee
Download Corporate Governance DocumentationCompliance Committee
Governance Documents
Download Corporate Governance DocumentationCode of Business Conduct and Ethics
Download Corporate Governance DocumentationClawback & Recoupment Policy
Download Corporate Governance DocumentationCorporate Governance Principles